VBI Vaccines Inc (VBIV) WACC Analysis

As of May 23, 2025, VBI Vaccines Inc (VBIV) carries a Weighted Average Cost of Capital (WACC) of 8.4%. WACC reflects the blended rate VBI Vaccines Inc must pay to both equity and debt holders.

Within that, the cost of equity is 12.5%, the cost of debt is 7.0%, and the effective tax rate is 26.2%.

Breakdown of WACC Components

• Long-term bond rate: 3.9% – 4.4%
• Equity market risk premium: 4.6% – 5.6%
• Adjusted beta: 1.88 – 7.28
• Additional risk adjustment: 0.0% – 0.5%
• Debt-to-equity ratio: 13.32

What It Means for Investors

With a selected WACC of 8.4%, VBI Vaccines Inc must ensure any new investment returns exceed this threshold to generate shareholder value. This level reflects a moderate financing cost structure.